Juan Carlos Lopez-Talavera, MD, PhD
Fractyl Laboratories, Inc., Lexington, Massachusetts
Juan Carlos Lopez-Talavera, M.D., Ph.D. is Chief Medical Officer of Fractyl. Juan Carlos is a pharmaceutical expert in all aspects of research and development with more than 15 years of industry experience, from disease pathogenesis, target identification, pre-clinical and clinical development through to medical affairs for marketed products. He has published more than 50 peer-reviewed original manuscripts.
Most recently, he served as Chief Medical Officer of Enterome Biosciences, where he led the company’s pipeline and clinical and pre-clinical development programs, clinical regulatory affairs and patient engagement.
Prior to joining Enterome, he held RnD executive positions in large pharma at Intercept Pharmaceuticals, AbbVie, Bristol Myers Squibb, and Roche Laboratories. He holds an M.D. and a Ph.D. in Hepatology from Universidad Autónoma de Barcelona, a postdoctoral fellowship at Yale University and was Assistant Professor at University of Pittsburgh.